Mosunetuzumab, the first bispecific approved for follicular lymphoma

Clin Adv Hematol Oncol. 2023 Oct;21(10):529-531.

Author

Lihua Elizabeth Budde^{1

2}

Affiliations

¹ Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
² Immune Effector Cell Program, City of Hope, Duarte, California.

PMID: 37948588

No abstract available

Publication types

Interview